ORGANOID SCIENCES Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 86

Employees

  • Stock Symbol
  • 476040

Stock Symbol

  • Share Price
  • $4.07
  • (As of Friday Closing)

ORGANOID SCIENCES General Information

Description

Organoidsciences Ltd is a biotechnology company specializing in organoid technology, developing regenerative therapeutics and drug discovery solutions based on three-dimensional organoids. Its business includes ATORM, an organoid-based regenerative therapeutics pipeline, and ODISEI, an organoid-based drug discovery platform. ATORM is a regenerative therapeutic pipeline leveraging organoids derived from various human tissues, including the intestine and salivary gland, to develop novel treatments for a wide range of diseases. ODISEI is an organoid-based drug discovery solution that utilizes disease-specific organoids-including tumor, viral infection, intestinal, and skin organoids-to predict and evaluate human biological responses.

Contact Information

Website
www.organoidrx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 154, Osongsaengmyeong 2-ro
  • Osong-eup, Heungdeok-gu
  • Cheongju, Gyeonggi-do 13493
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 154, Osongsaengmyeong 2-ro
  • Osong-eup, Heungdeok-gu
  • Cheongju, Gyeonggi-do 13493
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ORGANOID SCIENCES Stock Performance

As of 30-Oct-2026, ORGANOID SCIENCES’s stock price is $4.07. Its current market cap is $26.8M with 6.59M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.07 $4.24 $4.04 - $32.86 $26.8M 6.59M 22K -$1.92

ORGANOID SCIENCES Financials Summary

As of 30-Jun-2026, ORGANOID SCIENCES has a trailing 12-month revenue of $1.58M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 37,975 164,131
Revenue 1,577 1,691 1,432 1,217
EBITDA (11,514) (9,917) (5,514) (24,978)
Net Income (12,708) (10,799) (8,243) (29,590)
Total Assets 37,503 25,829 17,578 25,418
Total Debt 10,547 4,899 5,494 3,791
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ORGANOID SCIENCES Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ORGANOID SCIENCES‘s full profile, request access.

Request a free trial

ORGANOID SCIENCES Patents

  • 64

    Total Documents Applications and Grants

  • Total Patents Families

  • 24

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

ORGANOID SCIENCES Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025154961-A1 Cosmetic composition comprising organoid culture medium Pending 15-Jan-2024
EP-4818309-A1 Novel method for preparing skin organoid Pending 30-Nov-2023
WO-2025116671-A1 Novel method for preparing skin organoid Inactive 30-Nov-2023
US-20260201340-A1 Medium composition for preparation of cancer organoid Pending 30-Nov-2022
WO-2024117655-A1 Medium composition for preparing cancer organoid Inactive 30-Nov-2022 C12N5/0693
To view ORGANOID SCIENCES’s complete patent history, request access »

ORGANOID SCIENCES Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ORGANOID SCIENCES Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ORGANOID SCIENCES‘s full profile, request access.

Request a free trial

ORGANOID SCIENCES ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view ORGANOID SCIENCES’s complete esg history, request access »

ORGANOID SCIENCES FAQs

  • When was ORGANOID SCIENCES founded?

    ORGANOID SCIENCES was founded in 2018.

  • Where is ORGANOID SCIENCES headquartered?

    ORGANOID SCIENCES is headquartered in Cheongju, South Korea.

  • What is the size of ORGANOID SCIENCES?

    ORGANOID SCIENCES has 86 total employees.

  • What industry is ORGANOID SCIENCES in?

    ORGANOID SCIENCES’s primary industry is Drug Discovery.

  • Is ORGANOID SCIENCES a private or public company?

    ORGANOID SCIENCES is a Public company.

  • What is ORGANOID SCIENCES’s stock symbol?

    The ticker symbol for ORGANOID SCIENCES is 476040.

  • What is the current stock price of ORGANOID SCIENCES?

    As of 30-Oct-2026 the stock price of ORGANOID SCIENCES is $4.07.

  • What is the current market cap of ORGANOID SCIENCES?

    The current market capitalization of ORGANOID SCIENCES is $26.8M.

  • What is ORGANOID SCIENCES’s current revenue?

    The trailing twelve month revenue for ORGANOID SCIENCES is $1.58M.

  • What is ORGANOID SCIENCES’s annual earnings per share (EPS)?

    ORGANOID SCIENCES’s EPS for 12 months was -$1.92.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process